Feds charge Osiris ex­ecs with cook­ing the books as stock price soared

In­vestors might re­mem­ber how in­ter­est in the stock of the lit­tle re­gen­er­a­tive med biotech Osiris Ther­a­peu­tics $OSIR hit a fever pitch in the sum­mer of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.